<p>Cartesian Growth Co. II（纳斯达克代码：RENE - 获取免费报告）在二月份经历了空头头寸的大幅下降。截至 2 月 15 日，空头头寸总计为 300 股，较 1 月 31 日的 400 股下降了 25.0%。根据平均每日交易量 9,500 股，目前的覆盖天数比率为 0.0 天。</p>
<h2>Cartesian Growth Co. II 的机构交易</h2>
<p>机构投资者和对冲基金最近调整了对该股票的持有。Cantor Fitzgerald L. P. 在第四季度购买了价值约 22,125,000 美元的 Cartesian Growth Co. II 的新股份。瑞穗证券美国有限公司在第三季度将其在 Cartesian Growth Co. II 的持股增加了 151.2%。瑞穗证券美国有限公司目前拥有 987,500 股该公司的股票，价值 11,307,000 美元，在此期间又购买了 594,424 股。Westchester Capital Management LLC 在第三季度将其在 Cartesian Growth Co. II 的股份增加了 28.8%。Westchester Capital Management LLC 目前拥有 1,611,362 股该公司的股票，价值 18,466,000 美元，在上个季度又购买了 359,991 股。Crossingbridge Advisors LLC 在第三季度将其在 Cartesian Growth Co. II 的持股增加了 48.6%。Crossingbridge Advisors LLC 目前拥有 790,263 股该公司的股票，价值 9,061,000 美元，在此期间又购买了 258,390 股。最后，Alpine Global Management LLC 在第四季度购买了价值 2,332,000 美元的 Cartesian Growth Co. II 的新头寸。机构投资者持有该公司 58.96% 的股票。</p>
<h2>Cartesian Growth Co. II 股票表现</h2>
<p>纳斯达克：RENE 周一开盘价为 11.73 美元。该股票的 50 日移动平均线为 11.73 美元，200 日移动平均线为 11.59 美元。Cartesian Growth Co. II 的 52 周低点为 11.05 美元，52 周高点为 11.80 美元。</p>
<h2>Cartesian Growth Co. II 公司简介</h2>
<p>（获取免费报告）</p>
<p>Cartesian Growth Corp. II 作为一家空白支票公司运营。它的成立目的是进行合并、资本股票交换、资产收购、股票购买、重组或与一家或多家企业进行类似的商业组合。该公司成立于 2021 年 10 月 13 日，总部位于纽约，纽约州。</p>
<h2>进一步阅读</h2>
<ul>
<li>五只我们更看好的股票，胜过 Cartesian Growth Co. II</li>
<li>如何投资生物科技股票</li>
<li>混乱与现金：在波动中寻找机会</li>
<li>你应该将这些沃伦·巴菲特的股票加入你的投资组合吗？</li>
<li>Realty Income：在波动市场中的锚</li>
<li>投资建筑股票</li>
<li>Autodesk 为投资者设计价值：上升趋势将持续</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对本故事有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Cartesian Growth Co. II 吗？</h2>
<p>在考虑 Cartesian Growth Co. II 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Cartesian Growth Co. II 并不在名单上。</p>
<p>虽然 Cartesian Growth Co. II 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

RENE

RENEF

<p>Cartesian Growth Co. II (NASDAQ:RENE) 的空头头寸截至 2 月 15 日下降了 25%，降至 300 股，覆盖天数比率为 0.0 天。机构投资者持有该股票的 58.96%，其中瑞穗证券等公司的持股显著增加。该股票开盘价为 11.73 美元，52 周价格区间为 11.05 美元至 11.80 美元。分析师对其评级为持有，建议其他股票可能是更好的投资选择</p>

<p>Cartesian Growth Co. II (NASDAQ:RENE - Get Free Report) was the recipient of a large decline in short interest in the month of February. As of February 15th, there was short interest totalling 300 shares, a decline of 25.0% from the January 31st total of 400 shares. Based on an average daily volume of 9,500 shares, the days-to-cover ratio is currently 0.0 days.</p>
<div class="lb-trans"><p>Cartesian Growth Co. II（纳斯达克代码：RENE - 获取免费报告）在二月份经历了空头头寸的大幅下降。截至 2 月 15 日，空头头寸总计为 300 股，较 1 月 31 日的 400 股下降了 25.0%。根据平均每日交易量 9,500 股，目前的覆盖天数比率为 0.0 天。</p>
</div><h2>Institutional Trading of Cartesian Growth Co. II</h2>
<div class="lb-trans"><h2>Cartesian Growth Co. II 的机构交易</h2>
</div><p>Institutional investors and hedge funds have recently modified their holdings of the stock. Cantor Fitzgerald L. P. bought a new stake in shares of Cartesian Growth Co. II in the 4th quarter valued at about $22,125,000. Mizuho Securities USA LLC increased its holdings in Cartesian Growth Co. II by 151.2% during the third quarter. Mizuho Securities USA LLC now owns 987,500 shares of the company's stock valued at $11,307,000 after buying an additional 594,424 shares during the period. Westchester Capital Management LLC raised its stake in Cartesian Growth Co. II by 28.8% in the third quarter. Westchester Capital Management LLC now owns 1,611,362 shares of the company's stock worth $18,466,000 after buying an additional 359,991 shares in the last quarter. Crossingbridge Advisors LLC lifted its holdings in Cartesian Growth Co. II by 48.6% during the third quarter. Crossingbridge Advisors LLC now owns 790,263 shares of the company's stock worth $9,061,000 after buying an additional 258,390 shares during the period. Finally, Alpine Global Management LLC purchased a new position in shares of Cartesian Growth Co. II in the 4th quarter valued at $2,332,000. Institutional investors own 58.96% of the company's stock.</p>
<div class="lb-trans"><p>机构投资者和对冲基金最近调整了对该股票的持有。Cantor Fitzgerald L. P. 在第四季度购买了价值约 22,125,000 美元的 Cartesian Growth Co. II 的新股份。瑞穗证券美国有限公司在第三季度将其在 Cartesian Growth Co. II 的持股增加了 151.2%。瑞穗证券美国有限公司目前拥有 987,500 股该公司的股票，价值 11,307,000 美元，在此期间又购买了 594,424 股。Westchester Capital Management LLC 在第三季度将其在 Cartesian Growth Co. II 的股份增加了 28.8%。Westchester Capital Management LLC 目前拥有 1,611,362 股该公司的股票，价值 18,466,000 美元，在上个季度又购买了 359,991 股。Crossingbridge Advisors LLC 在第三季度将其在 Cartesian Growth Co. II 的持股增加了 48.6%。Crossingbridge Advisors LLC 目前拥有 790,263 股该公司的股票，价值 9,061,000 美元，在此期间又购买了 258,390 股。最后，Alpine Global Management LLC 在第四季度购买了价值 2,332,000 美元的 Cartesian Growth Co. II 的新头寸。机构投资者持有该公司 58.96% 的股票。</p>
</div><h2>Cartesian Growth Co. II Stock Performance</h2>
<div class="lb-trans"><h2>Cartesian Growth Co. II 股票表现</h2>
</div><p>NASDAQ:RENE opened at $11.73 on Monday. The stock's fifty day moving average is $11.73 and its 200 day moving average is $11.59. Cartesian Growth Co. II has a fifty-two week low of $11.05 and a fifty-two week high of $11.80.</p>
<div class="lb-trans"><p>纳斯达克：RENE 周一开盘价为 11.73 美元。该股票的 50 日移动平均线为 11.73 美元，200 日移动平均线为 11.59 美元。Cartesian Growth Co. II 的 52 周低点为 11.05 美元，52 周高点为 11.80 美元。</p>
</div><h2>Cartesian Growth Co. II Company Profile</h2>
<div class="lb-trans"><h2>Cartesian Growth Co. II 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Cartesian Growth Corp. II operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on October 13, 2021 and is headquartered in New York, NY.</p>
<div class="lb-trans"><p>Cartesian Growth Corp. II 作为一家空白支票公司运营。它的成立目的是进行合并、资本股票交换、资产收购、股票购买、重组或与一家或多家企业进行类似的商业组合。该公司成立于 2021 年 10 月 13 日，总部位于纽约，纽约州。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Cartesian Growth Co. II</li>
<li>How to Invest in Biotech Stocks</li>
<li>Chaos and Cash: Finding Opportunity in Volatility</li>
<li>Should You Add These Warren Buffett Stocks to Your Portfolio?</li>
<li>Realty Income: An Anchor in Volatile Markets</li>
<li>Investing in Construction Stocks</li>
<li>Autodesk Designs Value for Investors: Uptrend Set to Continue</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Cartesian Growth Co. II</li>
<li>如何投资生物科技股票</li>
<li>混乱与现金：在波动中寻找机会</li>
<li>你应该将这些沃伦·巴菲特的股票加入你的投资组合吗？</li>
<li>Realty Income：在波动市场中的锚</li>
<li>投资建筑股票</li>
<li>Autodesk 为投资者设计价值：上升趋势将持续</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对本故事有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Cartesian Growth Co. II Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Cartesian Growth Co. II 吗？</h2>
</div><p>Before you consider Cartesian Growth Co. II, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Cartesian Growth Co. II 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cartesian Growth Co. II wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Cartesian Growth Co. II 并不在名单上。</p>
</div><p>While Cartesian Growth Co. II currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Cartesian Growth Co. II 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Cartesian Growth II (NASDAQ:RENE) 空头头寸显著下降